ASCO 2022 Conference Coverage
Playback speed
10 seconds
ASCO 2022 Preliminary Analysis of an Expanded Access Study of the Fixed-Dose Combination of Pertuzumab & Trastuzumab for Subcutaneous Injection for At-Home Administration in HER2+ BC During the COVID-19 Pandemic
By
ASCO 2022 Conference Coverage
FEATURING
Chau Dang
By
ASCO 2022 Conference Coverage
FEATURING
Chau Dang
188 views
June 21, 2022
Login to view comments.
Click here to Login
Breast